These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32358512)

  • 21. The Fruit of Gold: Biomimicry in the Syntheses of Lankacidins.
    Zheng K; Hong R
    Acc Chem Res; 2021 Sep; 54(17):3438-3451. PubMed ID: 34383479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
    Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
    Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of multidrug resistance.
    Sonneveld P; Wiemer E
    Curr Opin Oncol; 1997 Nov; 9(6):543-8. PubMed ID: 9370075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collateral sensitivity of drug-resistant ABCB5- and mutation-activated EGFR overexpressing cells towards resveratrol due to modulation of SIRT1 expression.
    Saeed MEM; Rahama M; Kuete V; Dawood M; Elbadawi M; Sugimoto Y; Efferth T
    Phytomedicine; 2019 Jun; 59():152890. PubMed ID: 30921566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism.
    Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA
    Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
    Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA
    J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
    Wei G; Yang G; Wei B; Wang Y; Zhou S
    Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators.
    Krishna R; Mayer LD
    Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):163-74. PubMed ID: 12678765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.
    Bar-Zeev M; Kelmansky D; Assaraf YG; Livney YD
    Eur J Pharm Biopharm; 2018 Dec; 133():240-249. PubMed ID: 30367935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
    Dinić J; Podolski-Renić A; Jeremić M; Pešić M
    Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
    Brooks TA; Minderman H; O'Loughlin KL; Pera P; Ojima I; Baer MR; Bernacki RJ
    Mol Cancer Ther; 2003 Nov; 2(11):1195-205. PubMed ID: 14617793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
    Waghray D; Zhang Q
    J Med Chem; 2018 Jun; 61(12):5108-5121. PubMed ID: 29251920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
    Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M
    Molecules; 2017 May; 22(6):. PubMed ID: 28587082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
    Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
    Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance.
    Yuan H; Li X; Wu J; Li J; Qu X; Xu W; Tang W
    Curr Med Chem; 2008; 15(5):470-6. PubMed ID: 18289002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
    Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
    Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
    Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Smac mimetics as novel substrates for p-glycoprotein.
    Hugle M; Czaplinski S; Habermann K; Vogler M; Fulda S
    Cancer Lett; 2019 Jan; 440-441():126-134. PubMed ID: 30312727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.